{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:29:49Z","timestamp":1790094589112,"version":"4.0.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1093\/brain\/awt224","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T23:47:07Z","timestamp":1378165627000},"page":"3038-3050","source":"Crossref","is-referenced-by-count":118,"title":["Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson\u2019s disease"],"prefix":"10.1093","volume":"136","author":[{"given":"Heather","family":"Mortiboys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Aasly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Bandmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,9,2]]},"reference":[{"key":"key\n\t\t\t\t20170425190333_awt224-B1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t20170425190333_awt224-B2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12035-012-8295-4","article-title":"Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease","volume":"46","author":"Castro-Caldas","year":"2012","journal-title":"Mol Neurobiol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tox.2011.11.020","article-title":"Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells","volume":"292","author":"Chun","year":"2012","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20170425190333_awt224-B4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000325028","article-title":"Direct interaction of alpha-synuclein and AKT regulates IGF-1 signaling: implication of Parkinson disease","volume":"19","author":"Chung","year":"2011","journal-title":"Neurosignals"},{"key":"key\n\t\t\t\t20170425190333_awt224-B5","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddq167","article-title":"Parkinson's disease: insights from pathways","volume":"19","author":"Cookson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425190333_awt224-B6","doi-asserted-by":"crossref","first-page":"141ra190","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170425190333_awt224-B7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425190333_awt224-B8","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170425190333_awt224-B9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1441","article-title":"A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling","volume":"8","author":"Fallon","year":"2006","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","article-title":"Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment","volume":"31","author":"Greene","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.yfrne.2007.10.004","article-title":"The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings","volume":"29","author":"Haller","year":"2008","journal-title":"Front Neuroendocrinol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2010.10.014","article-title":"Genetic analysis of pathways to Parkinson disease","volume":"68","author":"Hardy","year":"2010","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170425190333_awt224-B13","doi-asserted-by":"crossref","first-page":"23622","DOI":"10.1074\/jbc.M313784200","article-title":"Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease","volume":"279","author":"Hashimoto","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B14","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/hmg\/ddt061","article-title":"Dopaminergic expression of the Parkinsonian gene LRRK2-G2019S leads to non-autonomous visual neurodegeneration, accelerated by increased neural demands for energy","volume":"22","author":"Hindle","year":"2013","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425190333_awt224-B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2047-9158-1-3","article-title":"Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease","volume":"1","author":"Ho","year":"2012","journal-title":"Transl Neurodegener"},{"key":"key\n\t\t\t\t20170425190333_awt224-B16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-4159.2009.06104.x","article-title":"Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients","volume":"110","author":"Kasher","year":"2009","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B17","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease","volume":"99","author":"Keene","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425190333_awt224-B18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","article-title":"mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass","volume":"13","author":"Kunkel","year":"2011","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170425190333_awt224-B19","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1474-4422(06)70605-6","article-title":"Neuroprotection in Parkinson's disease: and now for something completely different?","volume":"5","author":"Lang","year":"2006","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMc055540","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs","volume":"354","author":"Lesage","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425190333_awt224-B21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/cdd.2011.105","article-title":"Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease","volume":"19","author":"Lim","year":"2012","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20170425190333_awt224-B22","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1021\/np200060p","article-title":"Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria","volume":"74","author":"Liobikas","year":"2011","journal-title":"J Nat Prod"},{"key":"key\n\t\t\t\t20170425190333_awt224-B23","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1074\/jbc.M109.061051","article-title":"The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition","volume":"285","author":"Loeb","year":"2010","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B24","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","article-title":"RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation\/activation","volume":"28","author":"Malagelada","year":"2008","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170425190333_awt224-B25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170425190333_awt224-B26","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/0006-291X(89)91141-8","article-title":"Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease","volume":"163","author":"Mizuno","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170425190333_awt224-B27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e3181ff9685","article-title":"Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2","volume":"75","author":"Mortiboys","year":"2010","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425190333_awt224-B28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ana.21492","article-title":"Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts","volume":"64","author":"Mortiboys","year":"2008","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B29","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1074\/jbc.M110.179390","article-title":"A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK\/PINK1: activation of AKT via mTORC2","volume":"286","author":"Murata","year":"2011","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B30","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.febslet.2011.05.044","article-title":"LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations","volume":"585","author":"Ohta","year":"2011","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170425190333_awt224-B31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425190333_awt224-B32","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1093\/hmg\/dds244","article-title":"G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization","volume":"21","author":"Papkovskaia","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170425190333_awt224-B33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/WNF.0b013e3181c47569","article-title":"Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis","volume":"33","author":"Parry","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.molmed.2007.12.001","article-title":"Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease","volume":"14","author":"Ramalho","year":"2008","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20170425190333_awt224-B36","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1073\/pnas.1031632100","article-title":"Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats","volume":"100","author":"Rodrigues","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425190333_awt224-B37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.nbd.2010.05.014","article-title":"Trehalose ameliorates dopaminergic and tau pathology in parkin deleted\/tau overexpressing mice through autophagy activation","volume":"39","author":"Rodriguez-Navarro","year":"2010","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170425190333_awt224-B38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1089\/ars.2011.4419","article-title":"Targeting mitochondria for neuroprotection in Parkinson's disease","volume":"16","author":"Schapira","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"key\n\t\t\t\t20170425190333_awt224-B40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170425190333_awt224-B41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/jm100860s","article-title":"Ursodeoxycholic acid amides as novel glucocorticoid receptor modulators","volume":"54","author":"Sharma","year":"2011","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nn.2372","article-title":"Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss","volume":"12","author":"Tain","year":"2009","journal-title":"Nat Neurosci"},{"key":"key\n\t\t\t\t20170425190333_awt224-B43","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/0006-291X(92)91146-H","article-title":"Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor","volume":"188","author":"Tanaka","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170425190333_awt224-B44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","article-title":"Akt signal transduction dysfunction in Parkinson's disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170425190333_awt224-B45","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.1237908","article-title":"Structure of Parkin reveals mechanisms for ubiquitin ligase activation","volume":"340","author":"Trempe","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425190333_awt224-B46","doi-asserted-by":"crossref","first-page":"11180","DOI":"10.1074\/jbc.M700937200","article-title":"Thioredoxin suppresses Parkin-associated endothelin receptor-like receptor-induced neurotoxicity and extends longevity in Drosophila","volume":"282","author":"Umeda-Kameyama","year":"2007","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B47","doi-asserted-by":"crossref","first-page":"42655","DOI":"10.1074\/jbc.M505910200","article-title":"Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans","volume":"280","author":"Ved","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B48","doi-asserted-by":"crossref","first-page":"e1002456","DOI":"10.1371\/journal.pgen.1002456","article-title":"The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutants","volume":"8","author":"Vilain","year":"2012","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20170425190333_awt224-B49","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.1218632","article-title":"Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency","volume":"336","author":"Vos","year":"2012","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425190333_awt224-B50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003495-198427020-00001","article-title":"Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy","volume":"27","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170425190333_awt224-B51","doi-asserted-by":"crossref","first-page":"34914","DOI":"10.1074\/jbc.M111.232116","article-title":"A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36","volume":"286","author":"Wilkinson","year":"2011","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170425190333_awt224-B52","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1073\/pnas.0504610102","article-title":"Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase\/Akt signaling","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170425190333_awt224-B53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/NEN.0b013e3182269ecd","article-title":"Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease","volume":"70","author":"Yasuda","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170425190333_awt224-B54","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1021\/jf302529x","article-title":"Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice","volume":"60","author":"Yin","year":"2012","journal-title":"J Agric Food Chem"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/136\/10\/3038\/13795695\/awt224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T16:11:39Z","timestamp":1503418299000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awt224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,2]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,9,2]]},"published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awt224","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9,2]]}}}